Epilim Chronosphere 250mg prolonged-release granules
Authorisation PA0540/150/006 · Sanofi-Aventis Ireland Limited T/A SANOFI
- Licence holder
- Sanofi-Aventis Ireland Limited T/A SANOFI (all products →)
- Active substances
- Sodium valproate, Valproic acid
- Clinical trials
- 3 clinical trials → 4 clinical trials →
- Dosage form
- Prolonged-release granules
- Route of administration
- Oral use
- ATC codes
- N03AG, N03AG01
- First authorised
- 02/03/2007
- Prescription status
- Product subject to prescription which may be renewed (B)
- Supply
- Supply through pharmacies only
- Legal basis
- Full application (Article 8(3) of Directive No 2001/83/EC)
Sodium valproate: supply and approvals
13 authorised products on the HPRA list contain Sodium valproate. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 20 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 20 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 20 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
Valproic acid: supply and approvals
6 authorised products on the HPRA list contain Valproic acid. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 20 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 20 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 20 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 19 years (since 2 March 2007). The HPRA list marks it as marketed in Ireland.
Other medicines with Sodium valproate in Ireland
12 other products on the HPRA list contain Sodium valproate, from 2 licence holders; 12 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Epilim 100 mg Crushable Tablets | Sanofi-Aventis Ireland Limited T/A SANOFI | National authorisation (PA) | Marketed |
| Epilim Chrono 200mg Prolonged Release Tablets | Sanofi-Aventis Ireland Limited T/A SANOFI | National authorisation (PA) | Marketed |
| Epilim Chrono 300mg Prolonged Release Tablets | Sanofi-Aventis Ireland Limited T/A SANOFI | National authorisation (PA) | Marketed |
| Epilim Chrono 500mg Prolonged Release Tablets | Sanofi-Aventis Ireland Limited T/A SANOFI | National authorisation (PA) | Marketed |
| Epilim Chronosphere 100mg prolonged-release granules | Sanofi-Aventis Ireland Limited T/A SANOFI | National authorisation (PA) | Marketed |
| Epilim Chronosphere 500mg prolonged-release granules | Sanofi-Aventis Ireland Limited T/A SANOFI | National authorisation (PA) | Marketed |
| Epilim Enteric 200 mg gastro-resistant coated tablets | Sanofi-Aventis Ireland Limited T/A SANOFI | National authorisation (PA) | Marketed |
| Epilim Enteric 500mg Gastro-resistant Coated Tablets | Sanofi-Aventis Ireland Limited T/A SANOFI | National authorisation (PA) | Marketed |
| Epilim Intravenous 400mg powder and solvent for solution for injection or infusion | Sanofi-Aventis Ireland Limited T/A SANOFI | National authorisation (PA) | Marketed |
| Epilim Liquid 200 mg/5ml Oral Solution | Sanofi-Aventis Ireland Limited T/A SANOFI | National authorisation (PA) | Marketed |
| Epilim Syrup 200mg/5ml Oral Solution | Sanofi-Aventis Ireland Limited T/A SANOFI | National authorisation (PA) | Marketed |
| Sodium Valproate Seacross 100 mg/ml solution for injection/infusion | Seacross Pharma (Europe) Limited | National authorisation (PA) | Marketed |
Other medicines with Valproic acid in Ireland
5 other products on the HPRA list contain Valproic acid, from 1 licence holder; 5 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Epilim Chrono 200mg Prolonged Release Tablets | Sanofi-Aventis Ireland Limited T/A SANOFI | National authorisation (PA) | Marketed |
| Epilim Chrono 300mg Prolonged Release Tablets | Sanofi-Aventis Ireland Limited T/A SANOFI | National authorisation (PA) | Marketed |
| Epilim Chrono 500mg Prolonged Release Tablets | Sanofi-Aventis Ireland Limited T/A SANOFI | National authorisation (PA) | Marketed |
| Epilim Chronosphere 100mg prolonged-release granules | Sanofi-Aventis Ireland Limited T/A SANOFI | National authorisation (PA) | Marketed |
| Epilim Chronosphere 500mg prolonged-release granules | Sanofi-Aventis Ireland Limited T/A SANOFI | National authorisation (PA) | Marketed |
Other substances in ATC group N03AG
The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 2 other active substances share the group N03AG with this product:
Tiagabine (3) · Vigabatrin (2)
Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.
The licence holder
Sanofi-Aventis Ireland Limited T/A SANOFI holds 54 products on the HPRA list, with 22 different active substances; 47 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 21 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.